Arbeitspapier

An economic theory of statistical testing

This paper models the use of statistical hypothesis testing in regulatory approval. A privately informed agent proposes an innovation. Its approval is beneficial to the proponent, but potentially detrimental to the regulator. The proponent can conduct a costly clinical trial to persuade the regulator. I show that the regulator can screen out all ex-ante undesirable proponents by committing to use a simple statistical test. Its level is the ratio of the trial cost to the proponent's benefit from approval. In application to new drug approval, this level is around 15% for an average Phase III clinical trial.

Language
Englisch

Bibliographic citation
Series: cemmap working paper ; No. CWP50/16

Classification
Wirtschaft

Event
Geistige Schöpfung
(who)
Tetenov, Aleksey
Event
Veröffentlichung
(who)
Centre for Microdata Methods and Practice (cemmap)
(where)
London
(when)
2016

DOI
doi:10.1920/wp.cem.2016.5016
Handle
Last update
10.03.2025, 11:45 AM CET

Data provider

This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.

Object type

  • Arbeitspapier

Associated

  • Tetenov, Aleksey
  • Centre for Microdata Methods and Practice (cemmap)

Time of origin

  • 2016

Other Objects (12)